The 30-bp deletion variant: a polymorphism of latent membrane protein 1 prevalent in endemic and non-endemic areas of nasopharyngeal carcinomas in China

被引:53
作者
Zhang, XS
Song, KH
Mai, HQ
Jia, WH
Feng, BJ
Xia, JC
Zhang, RH
Huang, LX
Yu, XJ
Feng, QS
Huang, P
Chen, JJ
Zeng, YX
机构
[1] Sun Yatsen Univ Med Sci, Ctr Canc, Inst Canc, Guangzhou 510060, Peoples R China
[2] Sun Yatsen Univ Med Sci, Ctr Canc, Dept Nasopharyngeal Carcinomas, Guangzhou 510060, Peoples R China
关键词
Epstein-Barr virus; latent membrane protein 1; polymorphism; nasopharyngeal carcinoma;
D O I
10.1016/S0304-3835(01)00733-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Development of nasopharyngeal carcinoma (NPC) is closely associated with Epstein-Barr virus (EBV) infection. However, NPC occurs with a marked geographic and racial distribution, whereas EBV infection is ubiquitous in the world. This leads to a question whether certain subtypes of EBV have a greater potential to induce cell transformation. Latent membrane protein I (LMP1) is an EBV-encoded oncogenic protein and its 30-bp deleted variant (del-LMPl) has been reported to be predominant in biopsies of NPC. We have assessed the polymorphism of LMP1 in 47 biopsies of NPC, 107 cases of throat washings (TWs) from NPC patients, and 106 cases of TWs from non-NPC patients in Guangzhou, an endemic area of NPC in southern China, as well as 103 cases of TWs from healthy donors in Haerbin, a non-endemic area of NPC in northern China. Our results found a similar extent of the LMP1 polymorphism between NPC patients and non-NPC patients in Guangzhou, with the del-LMP1 being predominant in both Guangzhou and Haerbin. Sequence analyses showed identical substitutions in other coding regions Of the del-LMP1 isolated from Guangzhou and Haerbin. These results indicate that del-LMP1 represents a geographic or race-associated polymorphism rather than an NPC disease phenotype-associated polymorphism. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:65 / 73
页数:9
相关论文
共 64 条
[1]   EBV STRAIN VARIATION - GEOGRAPHICAL-DISTRIBUTION AND RELATION TO DISEASE STATE [J].
ABDELHAMID, M ;
CHEN, JJ ;
CONSTANTINE, N ;
MASSOUD, M ;
RAABTRAUB, N .
VIROLOGY, 1992, 190 (01) :168-175
[2]  
Ardila-Osorio H, 1999, INT J CANCER, V81, P645, DOI 10.1002/(SICI)1097-0215(19990517)81:4<645::AID-IJC22>3.0.CO
[3]  
2-0
[4]   Degradation of the Epstein-Barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway - Targeting via ubiquitination of the N-terminal residue [J].
Aviel, S ;
Winberg, G ;
Massucci, M ;
Ciechanover, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (31) :23491-23499
[5]  
BAICHWAL VR, 1988, ONCOGENE, V2, P461
[6]  
BAICHWAL VR, 1989, ONCOGENE, V4, P67
[7]   DETECTION OF AN EPSTEIN-BARR-VIRUS VARIANT IN T-CELL-LYMPHOMA TISSUES IDENTICAL TO THE DISTINCT STRAIN OBSERVED IN NASOPHARYNGEAL CARCINOMA IN THE TAIWANESE POPULATION [J].
CHANG, YS ;
SU, IJ ;
CHUNG, PJ ;
SHU, CH ;
NG, CK ;
WU, SJ ;
LIU, ST .
INTERNATIONAL JOURNAL OF CANCER, 1995, 62 (06) :673-677
[8]  
CHEN ML, 1992, ONCOGENE, V7, P2131
[9]  
Cheung ST, 1998, INT J CANCER, V76, P399, DOI 10.1002/(SICI)1097-0215(19980504)76:3<399::AID-IJC18>3.0.CO
[10]  
2-6